Methods and compositions for controlling efficacy of RNA silencing

Details for Australian Patent Application No. 2004248136 (hide)

Owner University of Massachusetts

Inventors Zamore, Phillip D.; Tang, Guiliang

Agent Watermark

Pub. Number AU-B-2004248136

PCT Pub. Number WO2004/111191

Priority 60/475,386 02.06.03 US

Filing date 2 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 15 September 2011

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/111191 Priority application(s): WO2004/111191

15 September 2011 Application Accepted

  Published as AU-B-2004248136

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004248138-Targeted delivery to legumain-expressing cells

2004248134-Fuel control mechansm and associated method of use